Please assess the completion status of the following clinical trial:

Trial Title: An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients suffering from non-small cell lung cancer (NSCLC) with clinical stage IIIB and IV tumours~* Patients with one chemotherapy regimen (first line treatment) (adjuvant chemotherapy following surgery is also regarded as first line treatment)~* Patients who are in transition from first to second line treatment~* Patients who signed an informed consent~Exclusion Criteria:~* Chemotherapy naïve patients~* Patients ever enrolled in clinical studies treating non-small cell lung cancer (NSCLC) with chemotherapy (during 1st and 2nd line chemotherapy)~* Patients who ever had chemotherapy for an indication other than NSCLC

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): Regular treatment for non-small cell lung cancer (NSCLC)

Based on this trial design, predict the completion outcome and termination type (if applicable).